Atlas Trials

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Clinical trial NCT06925685 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06925685
Sponsor
Allogene Therapeutics
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Hematologic MalignanciesSolid Tumors
Start date
2025-01-31
Primary completion
2039-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.